Pravin Dugel serves as the Executive Chair, President, and CEO of Ocular Therapeutix, Inc., where he leads a team focused on redefining the retinal disease experience for patients at risk of sight loss. With over 30 years of experience as a retina specialist, he is driven by a commitment to advancing retinal care and improving the quality of life for those affected by these conditions.

Throughout his career, Dugel has been a significant contributor to medical research and clinical development.